The global cannula market size is expected to reach USD 294.6 million by 2030, registering to grow at a CAGR of 7.6% from 2024 to 2030 according to a new report by Grand View Research, Inc. Increase in the prevalence of lifestyle diseases and an increase in awareness about minimally invasive surgeries are primary factors driving the growth of the cannula market. Other factors such as a rise in government initiatives to raise awareness about chronic diseases, new product launches, and technological advancements are also expected to boost the growth of the market during the forecast period.
The market observed a mixed impact due to the pandemic. While the dermatology segment experienced a sudden fall in sales in the first half of the pandemic due to the postponement of elective surgeries to adhere to the government-led guidelines and restrictions to curb the spread of the virus. On the other hand, the nasal cannula experienced a rise in demand due to its usage to treat patients infected with the COVID-19 virus. The dermatology segment is expected to experience a considerable amount of growth during the forecast period with things returning to normal due to the rise in patients opting for cosmetic surgeries.
Request a free sample copy or view the report summary: Cannula Market Report
Based on product, the market is segmented into cardiac, dermatology, nasal and others. The cardiac segment held the highest share in 2023 owing to the rise in the prevalence of cardiac diseases.
Based on type, the market is classified into neonatal cannulae, straight cannulae, winged cannulae, a wing with port, and winged with stopcork. The straight cannulae accounted for the highest market share in 2023 due to the high adoption rate as it is simpler to use.
Based on material, the is segmented into plastic, metal, and silicone. The Plastic segment dominated the market in 2023 with the highest share due to its increase in adoption rate in both in-patient and out-patient procedures.
Based on the size, the 18G size held the highest market share in 2023 owing to ease of use for both adults and adolescents to carry out a number of procedures.
Based on end-use, the market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment dominated the market due to an increase in hospitalization rate for a number of treatments.
In terms of region, North America accounted for the highest market share in 2023 owing to the availability of advanced healthcare infrastructure, increase in adoption of plastic surgery, and favorable government initiatives.
The COVID-19 pandemic had a mixed impact on the cannula market. While the dermatology segment experienced a significant fall in sales in the first half of the pandemic, the nasal cannula registered a major boost in sales during the pandemic.
Grand View Research has segmented the global cannula market based on product, type, size, material, end-use, and region:
Cannula Product Outlook (Revenue, USD Million, 2018 - 2030)
Cardiac
Arterial
Venous
Cardioplegia
Femoral
Dermatology
Nasal
Others
Cannula Type Outlook (Revenue, USD Million, 2018 - 2030)
Neonatal cannula
Straight cannula
Winged cannula
Wing With Port
Winged With Stop Cork
Cannula Material Outlook (Revenue, USD Million, 2018 - 2030)
Plastic
Metal
Silicone
Cannula Size Outlook (Revenue, USD Million, 2018 - 2030)
14G
16G
18G
20G
22G
24G
26G
Cannula End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital
Ambulatory Surgical Centers
Others
Cannula Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Cannula Market
Medtronic
Becton Dickinson (BD)
Edward Lifesciences
LivaNovaca
Smiths Medical
Boston Scientific Corporation
"The quality of research they have done for us has been excellent..."